Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02979340 · ClinicalTrials.gov registry record

MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
115
Enrollment target

NCT02979340 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 115 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02979340 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
115 participants
Enrollment target

Study Summary

Specific Aim 1. Determine if valid results of non-sedated MRI based assessments of liver stiffness and lipid content can be obtained in more than 90% of children and young adults with cystic fibrosis. Specific Aim 2. Determine hepatic lipid content using the HepaFat sequence and liver stiffness using MRE. Investigators will compare the results obtained by MRI with PUSH study grayscale ultrasounds in CF patients with normal, heterogeneous, homogeneous or nodular (cirrhotic) pattern on ultrasound. Specific Aim 3. Creation of an imaging core lab to centralize evaluation of MR imaging data, allow for remote image upload, electronic data storage, and remote image viewing/interpretation. This infrastructure will be utilized to standardize image post processing. Specific Aim 4. Using the longitudinal PUSH study, determine if MRI based imaging improves discrimination of subjects at risk for progression to advanced CF liver disease (development of cirrhosis) compared to using US imaging alone

Interventions

  • PROCEDURE MRI

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2017-01-27
Est. Completion 2019-12-27

What the Registry Record Tells You About NCT02979340

The ClinicalTrials.gov registry entry for NCT02979340 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.

NCT02979340 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02979340 about?

NCT02979340 is a clinical study titled "MRI to Characterize and Predict CF Liver Disease in PUSH Cohort". Specific Aim 1. Determine if valid results of non-sedated MRI based assessments of liver stiffness and lipid content can be obtained in more than 90% of children and young adults with cystic fibrosis. Specific Aim 2. Determine hepatic lipid content using the HepaFat sequence and liver stiffness usi...

What is the current status of trial NCT02979340?

This trial is currently completed. The enrollment target is 115 participants. The study started on 2017-01-27. Estimated completion is 2019-12-27.

What interventions are being tested in trial NCT02979340?

The interventions under investigation include: MRI (PROCEDURE).

Who is sponsoring clinical trial NCT02979340?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.